Edap Tms (NASDAQ:EDAP – Get Free Report) was downgraded by stock analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Tuesday.
Separately, HC Wainwright reissued a “buy” rating and set a $19.00 price target on shares of Edap Tms in a report on Thursday, August 29th.
Check Out Our Latest Stock Analysis on Edap Tms
Edap Tms Stock Performance
Edap Tms (NASDAQ:EDAP – Get Free Report) last released its quarterly earnings results on Wednesday, August 28th. The medical equipment provider reported ($0.18) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.04). The company had revenue of $16.97 million during the quarter, compared to the consensus estimate of $17.16 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. Equities analysts anticipate that Edap Tms will post -0.6 EPS for the current fiscal year.
Institutional Inflows and Outflows
Several hedge funds have recently made changes to their positions in EDAP. Virtu Financial LLC bought a new position in shares of Edap Tms in the first quarter worth $82,000. Redhawk Wealth Advisors Inc. bought a new position in Edap Tms in the 3rd quarter valued at about $36,000. BNP Paribas Financial Markets lifted its holdings in shares of Edap Tms by 23.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock worth $59,000 after acquiring an additional 4,400 shares during the period. Orion Capital Management LLC boosted its position in shares of Edap Tms by 10.4% during the 3rd quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock worth $178,000 after acquiring an additional 6,600 shares in the last quarter. Finally, Commonwealth Equity Services LLC increased its stake in Edap Tms by 5.9% in the second quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock valued at $388,000 after acquiring an additional 4,000 shares during the last quarter. 62.74% of the stock is owned by institutional investors.
Edap Tms Company Profile
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.
Recommended Stories
- Five stocks we like better than Edap Tms
- The How and Why of Investing in Gold Stocks
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- With Risk Tolerance, One Size Does Not Fit All
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- Want to Profit on the Downtrend? Downtrends, Explained.
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.